The Global BetaGlucan Based Products Market, by Source (Cereals, Yeast, Mushroom, andOthers), by Grade (Pharma, Medical, Food, Cosmetics, Enhanced Oil Recovery(EOR), and Animal Feed), and by Region (North America, Latin America, Europe,Asia Pacific, Middle East, and Africa), was valued at US$ 486.4 million in 2018and is projected to exhibit a CAGR of 7.2% during the forecast period (2018 -2026).
Beta glucans have been thesubject of intensifying research, owing to its beneficial role in loweringinsulin resistance and blood cholesterol, reducing the risk of obesity, and boostingthe immune system to fight cancer. Moreover, various health regulatory bodieshave approved beta glucan–containing foods to lower blood cholesterol levels by5% to 8%. These allow various keyplayers in the market to operate in beta glucan based products market and gainsignificant market share. For instance, in April 2019, Lantmännen acquired theoat ingredients business based in Kimstad, Sweden from Tate & Lyle.Moreover, Lantmännen’s acquisition of a Tate & Lyle’s mill and productionfacility for processing of oats in Kimstad will strengthen Lantmännen’sposition in the oats market. InNovember 2017, Naturex (now a subsidiary of Givaudan) acquired Swedish OatFiber, a specialized Sweden-based manufacturer with key international presence asa producer of oat beta glucans dietary fibers, oat oils, and oat proteins,addressing food industry, nutraceutical, cosmetic, and animal feedapplications. In December 2014, Leica Biosystems, a global leader in anatomicpathology laboratory solutions and instruments and subsidiary of DanaherCorporation, acquired Devicor Medical Products, Inc.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2597
In October 2014, NutraQ announcedthat it entered into a distribution partnership with American InternationalChemical LLC (AIC) to exclusively distribute the NBG range of beta-glucans inthe U.S., Canada, and Mexico.
Browse 32 Market Data Tables and30 Figures spread through 244 Pages and in-depth TOC on "Beta Glucan BasedProducts Market, by Source (Cereals, Yeast, Mushroom, and Others), by Grade(Pharma, Medical, Food, Cosmetics, Enhanced Oil Recovery (EOR), and AnimalFeed), and by Region (North America, Latin America, Europe, Asia Pacific,Middle East, and Africa) - Global Forecast to 2026"
Furthermore, the introduction ofregulations and gradually increasing research have resulted in increasingapplication areas of yeast Beta Glucan and increasing market size. Healthclaims for beta glucan containing foods have been allowed in the U.S., Canada,Sweden, Finland, and the U.K. since 2006. The health claims approved by the FDAand the European Food Safety Authority (EFSA) are based on research showingthat consuming 3 g of beta-glucans per day, from either oats or barley, canlower blood cholesterol levels by 6% to 8%. In May 2016, the FDA announced anew regulatory definition for dietary fiber and stated that to be considered asource of fiber, isolated or synthetic non-digestible carbohydrates must have ademonstrated physiological health benefit. Products that contain at least 0.75grams of beta-glucan per serving may use the FDA health claim: ‘Soluble fiberfrom foods such as oats, as part of a diet low in saturated fat andcholesterol, may reduce the risk of heart disease’.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/beta-glucan-based-products-market-2597
Key Takeaways of the Beta GlucanBased Products Market:
The global beta glucan basedproducts market is expected to witness a CAGR of 4.1% during the forecastperiod (2018 – 2026), owing to increasing engagement of key players in thismarket
Among source, the yeast segmentaccounted for major market share in 2017. Yeast derived beta glucan is one ofthe major products in the market with wide applications in management of highcholesterol levels and diabetes, and boosting immune system. This segment isexpected to witness significant growth over the forecast period, owing toincreasing awareness about immunity booster ingredients.
Among grade, pharma segment heldmajor market share in 2017. Beta glucan based products are extensively utilizedin pharma grade products such as health supplements powder, capsules, andtablets. Oat and barley are very rich sources of beta glucans, which showsimmunity modulator effect. Due to its immunity modulator effect, the pharmagrade beta glucans are expected to drive growth of the pharma segment over theforecast period.
Some of the major playersoperating in the global beta glucan based products market include Jkosmmune,Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH, KoninklijkeDSM N.V., Kerry Group PLC, STR Biotech Co. Ltd., Macrocare Tech Co., Ltd.,Amarte USA, LLC, Ceapro Inc., Biotec Pharmacon ASA, Quegen Biotech Co., Ltd.,Kemin Industries, Inc., NutraQ AS, Lantmännen, Carbon Medical Technologies,Inc., Givaudan SA, Danaher Corporation, Super Beta Glucan Inc., and AIPPO
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2597
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
